Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment

Autor: de Weerdt, Iris ^*, Hofland, Tom ^*, de Boer, Renate, Dobber, Johan A., Dubois, Julie, van Nieuwenhuize, Denise, Mobasher, Mehrdad, de Boer, Fransien, Hoogendoorn, Mels, Velders, Gerjo A., van der Klift, Marjolein, Remmerswaal, Ester B.M., Bemelman, Frederike J., Niemann, Carsten U., Kersting, Sabina, Levin, Mark-David, Eldering, Eric, Tonino, Sanne H., Kater, Arnon P.

Publikováno v: In Blood Advances 10 September 2019 3(17):2642-2652

Mixed T cell receptor dimers harbor potentially harmful neoreactivity

Autor: van Loenen, Marleen M., de Boer, Renate, Amir, Avital L., Hagedoorn, Renate S., Volbeda, Gerdien L., Willemze, Roelof, van Rood, Johannes J., Falkenburg, J. H. Frederik, Heemskerk, Mirjam H. M.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America, 2010 Jun . 107(24), 10972-10977.

Externí odkaz: https://www.jstor.org/stable/20724002

Allo-HLA reactivity of virus-specific memory T cells is common

Autor: Amir, Avital L, D'Orsogna, Lloyd J.A, Roelen, Dave L, van Loenen, Marleen M, Hagedoorn, Renate S, de Boer, Renate, van der Hoorn, Menno A.W.G, Kester, Michel G.D, Doxiadis, Ilias I.N, Falkenburg, J. H. Frederik, Claas, Frans H.J, Heemskerk, Mirjam H.M

Publikováno v: In Blood 15 April 2010 115(15):3146-3157

Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma

Autor: van den Berg, Joost H, Heemskerk, Bianca, van Rooij, Nienke, Gomez-Eerland, Raquel, Michels, Samira, van Zon, Maaike, de Boer, Renate, Bakker, Noor A M, Jorritsma-Smit, Annelies, van Buuren, Marit M, Kvistborg, Pia, Spits, Hergen, Schotte, Remko, Mallo, Henk, Karger, Matthias, van der Hage, Joris A, Wouters, Michel W J M, Pronk, Loes M, Geukes Foppen, Marnix H, Blank, Christian U, Beijnen, Jos H, Nuijen, Bastiaan, Schumacher, Ton N, Haanen, John B A G, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology

Publikováno v: Journal for immunotherapy of cancer, 8(2):e000848. BioMed Central Ltd.
Journal for ImmunoTherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for ImmunoTherapy of Cancer, 8(2). BioMed Central
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, 8(2). BMJ PUBLISHING GROUP

Treatment of metastatic melanoma with autologous tumor infiltrating lymphocytes (TILs) is currently applied in several centers. Robust and remarkably consistent overall response rates, of around 50% of treated patients, have been observed across hosp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cf62e6d6bc568457d18aa31e0f9752b
https://hdl.handle.net/1887/3182036

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.